List of works - Patrick J Commerford

Acute rheumatic fever

scientific article (June 2006)

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 27 July 2016

Apixaban in Patients with Atrial Fibrillation ⬇️

scientific article published on February 10, 2011

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

scientific article published on 25 July 2013

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

scientific article published on 27 October 2008

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry

scientific article

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes

Contemporary use of adjunctive corticosteroids in tuberculous pericarditis

scientific article published on 18 April 2007

Controversies in stable coronary artery disease

scientific article (publication date: 7 January 2006)

Controversies in ventricular remodelling

scientific article

Dronedarone in High-Risk Permanent Atrial Fibrillation

scientific article (publication date: 15 December 2011)

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

scientific article published on 2 May 2013

HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study

scientific article

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

scientific article published on 10 April 2013

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

scientific article

Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa.

scientific article published on January 2008

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

scientific article

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

scientific article published on 02 May 2019

Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic

scientific article published on July 2013

Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion

scientific article

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

scientific article

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

scientific article

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

scientific article

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

scientific article published on 10 November 2017

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

scientific article published on 29 May 2019

Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease

scientific article published on 02 January 2021

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.

scientific article published on 24 January 2014

List of works by Patrick J Commerford

Acute rheumatic fever

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

Apixaban in Patients with Atrial Fibrillation ⬇️

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes

Contemporary use of adjunctive corticosteroids in tuberculous pericarditis

Controversies in stable coronary artery disease

Controversies in ventricular remodelling

Dronedarone in High-Risk Permanent Atrial Fibrillation

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation

HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational study

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa.

Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

Prevalence of myocarditis and cardiotropic virus infection in Africans with HIV-associated cardiomyopathy, idiopathic dilated cardiomyopathy and heart transplant recipients: a pilot study: cardiovascular topic

Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.